Chart 1
Seroprevalence of SARS-CoV-2 antibodies from infection by the number of days between self-reported infection and date of test completion among Canadians 18 years and older living in private dwellings, April to August 2022

 Back to main article

Skip interactive chart, go to accessible chart description

Interactive - Selected Image CSV (1 KB)
>180 days 91-180 days 14-90 days <14 days 0 20 40 60 80 100 %
Source(s):
Canadian COVID-19 Antibody and Health Survey - Cycle 2 (5339).

Chart description


This is a bar clustered chart.

Seroprevalence of SARS-CoV-2 antibodies from infection by the number of days between self-reported infection and date of test completion among Canadians 18 years and older living in private dwellings, April to August 2022
  %
>180 days 68.0
91-180 days 86.3
14-90 days 89.9
&lt;14 days 55.0
Source(s):
Canadian COVID-19 Antibody and Health Survey - Cycle 2 (5339).
Date modified: